| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
ASND
Ascendis Pharma
|
Jun 17, 2026 | BUY |
Strong Buy
+17.0% avg upside
24 analysts
|
— | +0.0% |
|
ALNY
Alnylam Pharma
|
Jun 15, 2026 | BUY |
Strong Buy
+23.6% avg upside
51 analysts
|
— | · |
|
INSM
Insmed
|
Jun 08, 2026 | BUY |
Strong Buy
+82.2% avg upside
36 analysts
|
$179.00
86.89% Upside
|
+4.5% |
|
ONC
BeOne Medicines
|
Jun 02, 2026 | BUY |
Strong Buy
+28.4% avg upside
28 analysts
|
— | -4.4% |
|
JAZZ
Jazz Pharmaceuticals
|
Jun 02, 2026 | BUY |
Strong Buy
-1.8% avg upside
35 analysts
|
— | -0.7% |
|
AKTS
Aktis Oncology, Inc.
|
Feb 03, 2026 | BUY |
Strong Buy
+30.9% avg upside
8 analysts
|
$30.00
24.52% Upside
|
· |
|
NKTR
Nektar Therapeutics
|
Nov 09, 2025 | SELL |
Buy
+16.5% avg upside
25 analysts
|
$30.00
50.79% Downside
|
-5.1% |
|
IONS
Ionis Pharmaceuticals
|
Nov 09, 2025 | BUY |
Strong Buy
+13.3% avg upside
43 analysts
|
— | +5.4% |
|
STOK
Stoke Therapeutics
|
Nov 03, 2025 | HOLD |
Strong Buy
+25.1% avg upside
18 analysts
|
$25.00
19.43% Downside
|
+14.9% |
|
DNLI
Denali Therapeutics
|
Nov 03, 2025 | BUY |
Strong Buy
+60.2% avg upside
24 analysts
|
$26.00
11.57% Upside
|
+42.8% |
|
HALO
Halozyme
|
Oct 27, 2025 | HOLD |
Strong Buy
-13.7% avg upside
20 analysts
|
$65.00
5.23% Downside
|
+4.1% |
|
NVCR
NovoCure
|
Oct 27, 2025 | HOLD |
Strong Buy
+242.4% avg upside
11 analysts
|
$23.00
60.97% Upside
|
+29.5% |
|
BMRN
BioMarin Pharmaceutical
|
Oct 27, 2025 | BUY |
Strong Buy
+72.8% avg upside
52 analysts
|
— | +4.5% |
|
MRNA
Moderna
|
Oct 23, 2025 | SELL |
Hold
+6.1% avg upside
38 analysts
|
$25.00
61.00% Downside
|
-143.7% |
|
BNTX
BioNTech SE
|
Oct 23, 2025 | HOLD |
Strong Buy
+50.5% avg upside
26 analysts
|
$120.00
32.01% Upside
|
-13.2% |
|
INCY
Incyte
|
Oct 20, 2025 | HOLD |
Buy
+1.0% avg upside
47 analysts
|
— | +14.9% |
|
AMRN
Amarin
|
Oct 17, 2025 | SELL |
Buy
-47.3% avg upside
18 analysts
|
$10.00
37.52% Downside
|
+19.7% |
|
SRRK
Scholar Rock Holding
|
Oct 13, 2025 | BUY |
Strong Buy
+20.1% avg upside
23 analysts
|
— | +37.0% |
|
LEGN
Legend Biotech
|
Oct 09, 2025 | BUY |
Strong Buy
+140.3% avg upside
27 analysts
|
$76.00
172.07% Upside
|
+11.3% |
|
VRTX
Vertex Pharmaceuticals
|
Oct 08, 2025 | BUY |
Strong Buy
-2.6% avg upside
61 analysts
|
$530.00
17.40% Upside
|
+9.0% |
|
CRNX
Crinetics Pharmaceuticals
|
Sep 24, 2025 | BUY |
Strong Buy
+121.2% avg upside
20 analysts
|
$52.00
44.87% Upside
|
-5.3% |
|
MIRM
Mirum Pharmaceuticals
|
Sep 12, 2025 | BUY |
Strong Buy
+7.0% avg upside
21 analysts
|
$77.00
28.15% Downside
|
+44.2% |
|
UTHR
United Therapeutics
|
Sep 09, 2025 | BUY |
Buy
-18.7% avg upside
26 analysts
|
$450.00
16.07% Downside
|
+32.9% |
|
ALKS
Alkermes
|
Sep 09, 2025 | HOLD |
Strong Buy
-17.6% avg upside
34 analysts
|
$35.00
22.24% Downside
|
+62.8% |
|
MBX
MBX Biosciences, Inc.
|
Jun 16, 2025 | BUY |
Strong Buy
+53.4% avg upside
14 analysts
|
— | +281.8% |
|
BCRX
BioCryst
|
May 06, 2025 | BUY |
Strong Buy
+103.3% avg upside
24 analysts
|
$13.00
44.54% Upside
|
-14.0% |
|
IMCR
Immunocore Holdings
|
Apr 11, 2025 | BUY |
Strong Buy
+124.3% avg upside
22 analysts
|
$50.00
74.75% Upside
|
+16.8% |
|
EBS
Emergent Biosolutions
|
Nov 20, 2023 | SELL |
Buy
+216.6% avg upside
9 analysts
|
— | -322.9% |
|
ESPR
Esperion
|
Nov 20, 2023 | HOLD |
Buy
+701.2% avg upside
22 analysts
|
— | +97.5% |
|
ZYME
Zymeworks
|
Jun 07, 2022 | HOLD |
Strong Buy
+40.3% avg upside
25 analysts
|
$14.00
39.57% Downside
|
+31.7% |
|
LXRX
Lexicon Pharmaceuticals
|
Apr 07, 2022 | HOLD |
Buy
+98.7% avg upside
9 analysts
|
$5.00
148.80% Upside
|
-11.9% |
|
TVRD
Tvardi Therapeutics
|
Mar 14, 2022 | BUY |
Buy
+585.4% avg upside
23 analysts
|
$19.00
622.44% Upside
|
-50.6% |
|
APRE
Aprea Therapeutics
|
Aug 20, 2021 | SELL |
Buy
+3098.2% avg upside
7 analysts
|
— | +76.0% |
|
DNTH
Dianthus Therapeutics
|
Aug 03, 2021 | HOLD |
Strong Buy
+8.8% avg upside
29 analysts
|
$7.00
91.53% Downside
|
-74.2% |
|
KLDO
Kaleido Biosciences
|
Oct 14, 2020 | SELL |
Buy
+13249900.0% avg upside
5 analysts
|
$10.00
9999900.08% Upside
|
+46.1% |
|
YUM
Yum! Brands
|
Apr 06, 2020 | HOLD |
Buy
+1.0% avg upside
38 analysts
|
$66.00
56.53% Downside
|
+65.0% |
|
NVAX
Novavax
|
Mar 19, 2018 | SELL |
Buy
+154.1% avg upside
20 analysts
|
— | +73.7% |
|
ENTA
Enanta Pharmaceuticals
|
Feb 08, 2018 | HOLD |
Buy
+159.2% avg upside
17 analysts
|
$95.00
650.44% Upside
|
+21.4% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.